Ketamine for PTSD: How It Works, Research Evidence, and What to Expect
PTSD is one of the most treatment-resistant mental health conditions. About 30-40% of patients do not respond adequately to first-line treatments (SSRIs and trauma-focused therapy). Ketamine therapy has emerged as a promising option for these patients, with rapid-acting effects that can break through where traditional treatments have stalled.
Why Traditional PTSD Treatments Fall Short
The two FDA-approved medications for PTSD (sertraline and paroxetine) work by modulating serotonin. They help many patients, but their effects take 4-8 weeks to develop, and response rates hover around 50-60%. For patients with severe, treatment-resistant PTSD, this is not good enough.
Trauma-focused psychotherapy (CPT, PE, EMDR) has stronger evidence but requires sustained emotional engagement with traumatic memories. Many patients cannot tolerate this process, drop out, or are too symptomatic to engage meaningfully.
This is where ketamine offers something different: rapid symptom reduction (often within hours rather than weeks) that can create a window of stability for patients to engage with therapy.
How Ketamine Works for PTSD
Ketamine operates through several mechanisms relevant to PTSD:
NMDA Receptor Blockade
Ketamine blocks NMDA glutamate receptors, which triggers a cascade of downstream effects including increased BDNF (brain-derived neurotrophic factor) and rapid synaptogenesis. In plain terms: ketamine helps the brain form new neural connections quickly. For PTSD, this may allow the brain to reprocess traumatic memories and form new, less distressing associations.
Fear Extinction Enhancement
PTSD involves impaired fear extinction. The brain gets stuck in a threat response loop. Preclinical research shows that ketamine enhances fear extinction learning, essentially helping the brain “unlearn” the exaggerated threat response. This is why some clinicians pair ketamine sessions with trauma-focused therapy: the ketamine may open a neuroplasticity window during which therapeutic processing is more effective.
Default Mode Network Disruption
The default mode network (DMN) is often hyperactive in PTSD, driving rumination, hypervigilance, and intrusive thoughts. Ketamine temporarily disrupts DMN connectivity, which may explain the subjective experience many patients describe: “a break from the constant noise in my head.”
What the Research Shows
- Feder et al. (2014): First RCT of IV ketamine for chronic PTSD. Single infusion produced rapid, significant reduction in PTSD symptoms within 24 hours. Published in JAMA Psychiatry.
- Feder et al. (2021): Repeated IV ketamine (6 infusions over 2 weeks) produced a 65% response rate in chronic PTSD patients. Effects persisted for weeks after the final infusion. Published in American Journal of Psychiatry.
- VA Studies: The Department of Veterans Affairs has funded multiple ketamine trials for combat-related PTSD. Results have generally been positive, though not all patients respond.
- Ketamine-assisted psychotherapy: Emerging data suggests that combining ketamine infusions with trauma-focused therapy may produce better outcomes than either alone.
Treatment Protocols
| Protocol | Route | Sessions | Notes |
|---|---|---|---|
| IV ketamine (standard) | Intravenous (0.5 mg/kg over 40 min) | 6 over 2-3 weeks | Most studied protocol for PTSD |
| IV ketamine + therapy | IV infusion + psychotherapy session | 6-12 | Growing evidence for enhanced outcomes |
| Intranasal esketamine (Spravato) | Nasal spray (FDA-approved for depression) | Twice weekly initially | FDA-approved for depression, off-label for PTSD |
| Oral/sublingual ketamine | Lozenge or tablet | Variable | Lower bioavailability, used for maintenance |
What to Expect
During the infusion: Most patients experience dissociative effects: altered perception of time, floating sensation, mild visual distortion. Some find this uncomfortable, others describe it as therapeutic in itself. Sessions last 40-60 minutes with a recovery period of 1-2 hours.
After: Many patients report a shift within 24-48 hours of the first infusion. Intrusive thoughts become less intense, hypervigilance decreases, and emotional reactivity softens. This is not the same as “feeling happy.” Patients describe it more as “the volume turned down on the constant alarm.”
Duration of effects: A single infusion may provide relief for days to 1-2 weeks. A full series (6 infusions) typically provides 3-6 weeks of sustained benefit. Maintenance sessions (monthly or as needed) are common for longer-term management.
Limitations and Considerations
- Not everyone responds: About 35% of PTSD patients do not show significant improvement with ketamine. Predictors of response are still being studied.
- Effects can be temporary: Without maintenance sessions or effective concurrent therapy, symptom improvement may fade over weeks.
- Dissociation can be triggering: For some PTSD patients, the dissociative effects of ketamine may trigger or mimic trauma-related dissociation. This should be discussed with the provider beforehand.
- Cost: $400-$800 per infusion, 6+ sessions recommended. Not covered by most insurance (Spravato may have some coverage). See our full ketamine therapy guide for cost details.
- Abuse potential: Ketamine has potential for misuse. It should only be administered in a clinical setting with proper monitoring.
Finding a Provider
- Look for psychiatrists or anesthesiologists with specific ketamine therapy experience.
- Providers who offer ketamine-assisted psychotherapy (KAP) combine the pharmacological and therapeutic approaches.
- VA medical centers are increasingly offering ketamine for treatment-resistant PTSD.
- Ask about monitoring protocols, screening criteria, and their experience with PTSD patients specifically.
